Main > A1. CORP. INDEX. Cn-Cz > Coley Pharmaceutical/P > 2005. 04.04.2005. (Pfizer)

---

On the good side, Pfizer announced that it is working with Coley Pharmaceutical to develop a Coley oligodeoxynucleotide that treats cancers by directing the body s immune system to deliver a targeted antitumor response. Pfizer will make an initial payment of $50 million with the potential for $455 million in milestone payments and royalties. Pfizer has also committed to investing $10 million in Coley s stock in the case of an initial public offering.


2005. 04.04.2005. (Pfizer)'s products
This section has no products